DigitalPersona, Inc., a trusted partner for biometric identity verification solutions, today announced that the DigitalPersona®Eikon® Touch 500 with TouchChip® TCS1 Sensor and U.are.U® 4500 Reader UID edition USB based single fingerprint scanners have been certified by the Standardisation Testing and Quality Certification (STQC) Directorate, an office of the Department of Electronics and Information Technology, Ministry of Communications & IT, Govt. of India. This certification was obtained in cooperation with DigitalPersona's partner in India, Smart Identity Devices Pvt. Ltd. (Smart ID).
In the perilous hours immediately after birth, a newborn mammal must survive the sudden loss of food supply from its mother. Under normal circumstances, newborns mount a metabolic response to ward off starvation until feeding occurs. This survival response involves a process of controlled breakdown of internal energetic sources known as autophagy. Although autophagy has been well documented, the key mechanistic regulators of autophagy in vivo have remained poorly understood.
Despite more than 25 years of research on antiobesity drugs, few medications have shown long-term success. Now researchers reporting online on December 21 in the Cell Press journal Trends in Endocrinology & Metabolism say that targeting taste sensors in the gut may be a promising new strategy.
T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the U.S. Patent and Trademark Office has issued patent number 8,334,693 (the ‘693 patent), “NMR device for detection of analytes”.
Plessey will be demonstrating its innovative handheld ECG monitor at CES 2013 on booth 73506 at the Venetian Hotel.
Fingerprint Cards (FPC) has received its second Design Win (DW) for its swipe sensor technology from one of Japan’s leading and most innovative mobile phone manufacturers. The initial volume is estimated at minimum one million mobile phones and the first model launch is scheduled for the second quarter of 2013. Due to the competitive situation, the mobile phone manufacturer wants to remain anonymous for the time being.
Vasily Kolchenko, associate professor of biological sciences at New York City College of Technology (City Tech), is a key player on a research team that recently made a breakthrough with enormous potential significance for the treatment of serious diseases.
African sleeping sickness is an infectious disease that is widespread south of the Sahara Desert. Although the around sixty million people residing in tropical Africa run the risk of becoming infected with the disease every day, only around four million of them are monitored for the disease by disease-control authorities. TU Darmstadt bioscientists have recently developed a biosensor that provides simple, cost-effective, means for diagnosing incidences of the disease before it breaks out.
BiOptix announced today that it will be showcasing the new BiOptix 404pi at IBC's 23rd Annual Antibody Engineering and Therapeutics Conference in San Diego. The conference, which runs December 2 – 6, 2012, is one of the preeminent technology symposia in the world for the international antibody development and research community.
Arizona State University’s team made a strong showing this fall in one of the most prominent international student engineering and science competitions.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.